Delcath (DCTH)
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The...
- Open
- 15.990
- High
- 16.000
- Low
- 15.730
- Prev. Close
- 15.800
- Volume
- 347.06K
- Turnover
- 5.52M
- Avg Price
- 15.892
- Bid/Ask Ratio
- --
- Amplitude
- 1.71%
- 52wk High
- 17.420
- Volume Ratio
- 1.11
- Turnover Ratio
- 1.21%
Delcath Analyst Rating
View moreForecast & Rating
Aug 7, 2026Price forecast
$24.0050.85%
Forecast & RatingStrong buy
5analysts
- Strong buy80.00%
- Buy20.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- StockTitan · 2 days ago, 12:01 PM
Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | DCTH Stock News
- PUBT · Aug 14 at 12:10 PM
Delcath Systems adopts Delaware Chancery Court as exclusive forum for internal corporate claims
- Global Report · Aug 13 at 09:43 AM
The Great Consumer Splinter: From Streaming Survival to Wild Crypto Pivots
